Letter by Bonassi Regarding Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"
- PMID: 31094268
- PMCID: PMC6585313
- DOI: 10.1161/JAHA.119.012315
Letter by Bonassi Regarding Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"
Comment in
-
Response to Letter by Bonassi on Article, "Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".J Am Heart Assoc. 2019 May 21;8(10):e012172. doi: 10.1161/JAHA.119.012172. J Am Heart Assoc. 2019. PMID: 31094263 Free PMC article. No abstract available.
Comment on
-
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Am Heart Assoc. 2018 Dec 18;7(24):e011245. doi: 10.1161/JAHA.118.011245. J Am Heart Assoc. 2018. PMID: 30561254 Free PMC article.
References
-
- Katsanos K, Spiliopoulos S, Kitrou P, Krokidis M, Karnabatidis D. Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245 DOI: 10.1161/JAHA.118.011245. - DOI - PMC - PubMed
-
- U.S. Food & Drug Administration. Treatment of Peripheral Arterial Disease with Paclitaxel‐Coated Balloons and Paclitaxel‐Eluting Stents Potentially Associated with Increased Mortality ‐ Letter to Health Care Providers. January 17, 2019. Available at https://www.fda.gov/MedicalDevices/Safety/LetterstoHealthCareProviders/u....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources